Reports

Reports
Spirogen Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
30

“Spirogen - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Spirogen. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase

Reports
Evotec AG Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
34

“Evotec AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Evotec AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in research phase.The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status

Reports
Hospira Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
33

“Hospira - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Hospira. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline and majority of them are in preregistration phase. There are 8 cancer drugs by Hospira which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points

Reports
Samyang Group Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
28

“Samyang Group - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Samyang Group. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline. There are 3 cancer drugs by Samyang Group which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of

Reports
Endocyte Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
32

“Endocyte - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Endocyte. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline.The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase of

Reports
Enzon Pharmaceuticals Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
31

“Enzon Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Enzon Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “4” cancer drugs in clinical pipeline. There are 2 cancer drugs by Enzon Pharmaceuticals which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of

Reports
Progenics Pharmaceuticals Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
34

“Progenics Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Progenics Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “10” cancer drugs in clinical pipeline and majority of them are in phase-I. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status

Reports
Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
139

“Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Eisai Co. Ltd. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “31” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 15 cancer drugs by Eisai Co. Ltd. which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying

Reports
Plexxikon Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
48

“Plexxikon - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Plexxikon. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline and majority of them are in phase-I. There are 3 cancer drugs by Plexxikon which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like

Reports
Dendreon Corporation Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
27

“Dendreon Corporation - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Dendreon Corporation. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline. There is 1 cancer drug by Dendreon Corporation which is commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of